| Tap a line for its trend | Last 12Mto Jun 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 1.19× | 1.19× | 28.17× | 7.22× | 27.57× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 0.09× | 0.09× | 0.07× | −0.23× | −0.04× | ||
| 0.00× | 0.00× | 0.00× | 0.02× | 0.01× | ||
| 0.23× | 0.23× | −0.22× | −0.03× | −0.67× | ||
| −32.50× | −32.50× | 2.97× | −1.84× | 0.75× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/06/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 27.57 | 7.22 | 28.17 | 1.19 | 1.19 | |
| Working Capital Turnover | -0.04 | -0.23 | 0.07 | 0.09 | 0.09 | |
| Asset Turnover | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 | |
| Cash Conversion (CFO/Net Income) | -0.67 | -0.03 | -0.22 | 0.23 | 0.23 | |
| CFO/EBITDA | 0.75 | -1.84 | 2.97 | -32.50 | -32.50 |